SEARCH FOR SCI CURE: new study proposes use of acteoside on chronic injuries

A group of researchers at the University of Toyama in Japan has focused on skeletal muscle atrophy as a detrimental factor in chronic SCI and explored drugs that protect against muscle atrophy and activate secretion of axonal growth factors from skeletal muscle. In doing so, they found that acteoside induced the secretion of axonal growth factors from skeletal muscle cells, resulting in proliferation of these cells. Intramuscular injection of acteoside in mice with chronic SCI recovered skeletal muscle weight reduction and motor function impairment.

You can read the complete study HERE.